title: A review of intracoronary abciximab in percutaneous coronary interventions--where are we now and where do we go from here?
abstract: The rationale for intracoronary administration of abciximab is discussed. The data on use of intracoronary abciximab in percutaneous coronary interventions in acute coronary syndromes and STEMI are reviewed. Evaluation of the niche where intracoronary administration of abciximab may be useful and future research into the subject and relevant patents are discussed.
authors: Sanjiv
authors: S
authors: Sharma
authors: Kumud
authors: K
authors: Bhalla
authors: Chairman, Dept of Medicine, Bakersfield Heart Hospital, 2901 Sillect Ave #100, Bakersfield, CA, USA 93308. Sanjiv1122@yahoo.com.
authors: Sarabjeet
authors: S
authors: Singh
mesh_terms: D000077284:Abciximab; D054058:Acute Coronary Syndrome / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000925:Anticoagulants / Q000627:therapeutic use*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D009203:Myocardial Infarction / Q000628:therapy*; D010330:Patents as Topic; D062645:Percutaneous Coronary Intervention / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab